Status:
TERMINATED
Contribution of Contrast Enhanced Ultrasound in the Diagnosis of Adnexal Torsion
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Adnexal Torsion
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
Clinical diagnosis of adnexal torsion is difficult because the symptomatology is dominated by abrupt onset pelvic pain, an aspecific sign which does not allow a diagnosis of certainty to be made. To ...
Detailed Description
The primary objective is to evaluate the diagnostic performance of contrast enhanced ultrasound for the diagnosis of adnexal torsion in women with suspected adnexal torsion. The secondary objectives ...
Eligibility Criteria
Inclusion
- Woman over 18 years old
- Woman affiliated to a social security
- Woman having received complete information on the organization of the research and having given her informed consent in written form.
- Planned surgical intervention for suspected adnexal torsion
Exclusion
- Patients under a measure of legal protection,
- Contraindication to contrast injection Hypersensitivity to sulfur hexafluoride or any of the other ingredients, history of cardiac disease, respiratory distress syndrome, severe pulmonary hypertension..
Key Trial Info
Start Date :
April 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 5 2023
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04522219
Start Date
April 13 2021
End Date
June 5 2023
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Régional Universitaire de Nancy
Nancy, France, 54000